Fatty Liver and Blood Sugar: What Links MASLD
Quick Facts
Why are fatty liver disease and high blood sugar connected?
Fatty liver discovered on a scan and elevated glucose found during a checkup can appear to be separate problems. A September 14 Harvard Health explainer by physician Howard E. LeWine emphasizes their shared metabolic background. It also highlights that fatty liver frequently accompanies high blood pressure, abnormal blood fats, and abdominal obesity, making the finding relevant beyond liver health. [Harvard Health](https://www.health.harvard.edu/diabetes-and-metabolic-health/is-there-a-link-between-fatty-liver-and-high-blood-sugar)
Insulin helps regulate blood glucose. When muscle, fat, and liver cells respond poorly to it, the pancreas may initially compensate by producing more insulin. Blood glucose can rise when that compensation becomes insufficient. This explains why insulin resistance can be present before diabetes is diagnosed, and why having fatty liver does not automatically mean someone already has diabetes. [NIDDK: Insulin Resistance and Prediabetes](https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/prediabetes-insulin-resistance)
MASLD is the term now used for the common metabolic form of fatty liver disease. Some people have fat accumulation with little inflammation; others develop metabolic dysfunction-associated steatohepatitis, or MASH, which includes inflammation and liver injury. Progression varies, so a diagnosis should prompt assessment rather than an assumption that severe damage is inevitable. [NIH: MASLD](https://health.nih.gov/health-topics-a-z/masld)
What tests help when fatty liver and high blood sugar occur together?
A glucose measurement needs context, including whether the person had eaten. A single mildly elevated nonfasting result does not establish diabetes. Clinicians may order fasting plasma glucose or an A1C test, which reflects average glucose over approximately three months. NIDDK lists an A1C of 5.7–6.4% as the prediabetes range and 6.5% or higher as the diabetes threshold. Without unequivocal hyperglycemia, abnormal results require confirmation. These are diagnostic thresholds, not universal treatment targets for people already receiving diabetes care. [NIDDK: The A1C Test and Diabetes](https://www.niddk.nih.gov/health-information/diagnostic-tests/a1c-test)
Liver assessment answers a different question: how much scarring, called fibrosis, may be present? European guidelines recommend a staged approach for people at increased risk, particularly those with type 2 diabetes. Clinicians can begin with FIB-4, a score calculated from age, liver enzymes, and platelet count, and arrange further testing when indicated. Elastography measures liver stiffness and can help determine whether specialist assessment is needed. Finding liver fat alone does not establish the extent of fibrosis. [EASL–EASD–EASO clinical practice guidelines](https://easlcampus.eu/sites/default/files/2024-06/EASL_CPGs_on_MASLD.pdf)
How can people improve liver health and blood sugar together?
Exercise is a central part of MASLD care because it can reduce liver fat even without substantial weight loss. European guidelines recommend activity adapted to a person's abilities and preferences, preferably more than 150 minutes of moderate activity or 75 minutes of vigorous activity weekly. Someone who is inactive can build toward that goal gradually. For people with overweight, sustained weight reduction can also improve liver health, although the response varies. [EASL–EASD–EASO clinical practice guidelines](https://easlcampus.eu/sites/default/files/2024-06/EASL_CPGs_on_MASLD.pdf)
Dietary changes should be practical enough to maintain. NIDDK recommends appropriate portion sizes, replacing saturated fats with unsaturated fats, and avoiding foods and drinks containing large amounts of simple sugars, particularly fructose. Examples include choosing water instead of sugary drinks and using unsaturated oils in place of butter. Alcohol intake also deserves discussion because it can contribute to liver damage. These changes form part of ongoing care, with glucose, blood pressure, and cholesterol managed according to the individual's needs. [NIDDK: Eating, Diet, and Nutrition for Fatty Liver Disease](https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash/eating-diet-nutrition)
Frequently Asked Questions
No. The conditions share risk factors, particularly insulin resistance, but diabetes requires appropriate blood testing. Fatty liver is a reason to discuss metabolic screening with your clinician.
Yes. People without obesity can develop fatty liver disease. Body size alone cannot establish or exclude the diagnosis, and metabolic risk factors should be considered individually.
It reaches the diagnostic threshold, but confirmation is generally needed unless hyperglycemia is unequivocal. A clinician can arrange repeat A1C or another appropriate laboratory test.
No. Disease progression varies. Some people develop inflammation and scarring, while others do not progress to advanced liver disease; fibrosis assessment helps identify those needing closer follow-up.
Yes. Exercise can reduce liver fat and improve metabolic health even without substantial weight loss. Activity should be adapted to your health, mobility, and starting fitness.
References
- LeWine HE. Is there a link between fatty liver and high blood sugar? Harvard Health Publishing. September 14, 2026. https://www.health.harvard.edu/diabetes-and-metabolic-health/is-there-a-link-between-fatty-liver-and-high-blood-sugar
- National Institute of Diabetes and Digestive and Kidney Diseases. Insulin Resistance & Prediabetes. https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/prediabetes-insulin-resistance
- National Institutes of Health. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). https://health.nih.gov/health-topics-a-z/masld
- National Institute of Diabetes and Digestive and Kidney Diseases. The A1C Test & Diabetes. https://www.niddk.nih.gov/health-information/diagnostic-tests/a1c-test
- EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Journal of Hepatology. 2024. https://easlcampus.eu/sites/default/files/2024-06/EASL_CPGs_on_MASLD.pdf
- National Institute of Diabetes and Digestive and Kidney Diseases. Eating, Diet, & Nutrition for NAFLD & NASH. https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash/eating-diet-nutrition